Orient Pharma Co Ltd (ROCO:4166)
NT$ 37.6 1.3 (3.58%) Market Cap: 8.39 Bil Enterprise Value: 8.87 Bil PE Ratio: 71.09 PB Ratio: 4.73 GF Score: 72/100

Orient Pharma Co Ltd (ROCO:4166) Transcripts

    • 1